Jeffrey M. Bergman - Concepedia

Author

Jeffrey M. Bergman

Also Known As

Bergman, Jeffrey M., J Bergman, J. BERGMAN, J. Bergman, J. M. BERGMAN, J. M. Bergman, Jeffrey Bergman, Jeffrey M Bergman, Jeffrey M. Bergman

Publications

786

Citations

H-Index

Concepts

All Affiliations

United States Military Academy

About

Jeffrey M. Bergman is an author at United States Military Academy specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	488
2	Biochemistry	7	7	223
3	Natural Sciences	5	5	126
4	Chemical Biology	2	2	56
5	Engineering	1	1	121

Jeffrey M. Bergman

Publications

634

Citations

H-Index

Page 1

	Year	Citations
Synthesis of carbazole alkaloids Jeffrey M. Bergman, Benjamin Pelcman Pure and Applied Chemistry Organic ChemistrySynthetic ChemistryPharmacologyCarbazole AlkaloidsNatural Product Synthesis	1990	124
Aspects of Interaction Between Plant Genotypes and Biological Control Jeffrey M. Bergman, Ward M. Tingey Bulletin of the Entomological Society of America EngineeringBotanyPlant Defense GeneGeneticsEntomology	1979	121
Two new groups of selective stimulants of adrenergicβ-receptors Jeffrey M. Bergman, Henry Persson, Kjell Wetterlin Cellular and Molecular Life Sciences Molecular PharmacologyMedicineSelective StimulantsReceptor (Biochemistry)Pharmacology	1969	100
Proline bis-amides as potent dual orexin receptor antagonists Jeffrey M. Bergman, Anthony J. Roecker, Swati P. Mercer, Bioorganic & Medicinal Chemistry Letters Proline Bis-amidesBiochemistryMedicineFunctional SelectivityMechanism Of Action	2008	71
<i>N</i>-Arylpiperazinone Inhibitors of Farnesyltransferase: Discovery and Biological Activity Theresa M. Williams, Jeffrey M. Bergman, Karen M. Brashear, Journal of Medicinal Chemistry Altmetric Attention ScorePharmacotherapyChemical BiologyPharmaceutical ChemistryTranslational Pharmacology	1999	45
Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I Jeffrey M. Bergman, Marc Abrams, Joseph P. Davide, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryDiversity Oriented SynthesisDual InhibitorsBiochemistryMedicine	2001	29
3,8-Diazabicyclo[3.2.1]octan-2-one Peptide Mimetics: Synthesis of a Conformationally Restricted Inhibitor of Farnesyltransferase Christopher J. Dinsmore, Jeffrey M. Bergman, Michael J. Bogusky, Organic Letters Bioorganic ChemistryOrganic ChemistryPeptide ScienceCalpha PositionChemistry	2001	29
Discovery of MK-3697: A selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia Anthony J. Roecker, Thomas S. Reger, M. Christa Mattern, Bioorganic & Medicinal Chemistry Letters SleepFunctional SelectivityMedicinePhysiologyReceptor Antagonist	2014	28
Oxo-piperazine Derivatives of N-Arylpiperazinones as Inhibitors of Farnesyltransferase Christopher J Dinsmore, Jeffrey M. Bergman, Donna Wei, Bioorganic & Medicinal Chemistry Letters Oxo-piperazine DerivativesBiochemistryMedicineChemical DerivativeHeterocycle Chemistry	2001	25
Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements Anthony J. Roecker, Swati P. Mercer, Jeffrey M. Bergman, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicineOrganic ChemistryDiazepane Amide DorasChemistry	2015	16

Page 1